Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
69.8M
-
Shares change
-
+7.75M
-
Total reported value, excl. options
-
$860M
-
Value change
-
+$95.1M
-
Number of buys
-
80
-
Number of sells
-
-62
-
Price
-
$12.32
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q2 2019
154 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q2 2019.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.8M shares
of 374M outstanding shares and own 18.65% of the company stock.
Largest 10 shareholders include Levin Easterly Partners LLC (7.9M shares), PRIMECAP MANAGEMENT CO/CA/ (6.58M shares), Russell Investments Group, Ltd. (5.44M shares), Neuberger Berman Group LLC (5.1M shares), BlackRock Inc. (4.94M shares), VANGUARD GROUP INC (3.75M shares), RENAISSANCE TECHNOLOGIES LLC (2.52M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.14M shares), RTW INVESTMENTS, LP (2.08M shares), and FMR LLC (1.82M shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.